Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 26, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a distribution and supply agreement with Medical Futures Inc. ("Medical Futures"), a...
-
Sep 7, 2011
Cipher Pharmaceuticals Inc. (TSX: DND), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at the Rodman & Renshaw Annual Global Investment Conference, which...
-
Aug 31, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Health Canada has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately...
-
Jul 26, 2011
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2011 ("Q2 2011"). Q2 2011 Summary Licensed the U.S....
-
Jul 7, 2011
- Second quarter financial results to be released July 26, 2011 - Toronto Stock Exchange Symbol: DND MISSISSAUGA,ON, July 7, 2011 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...